Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    February 2019
  1. PINNIX CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, et al
    Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Feb 12. pii: S0360-3016(19)30192.
    PubMed     Text format     Abstract available


  2. MIKHAEEL NG, Milgrom SA, Terezakis S, Berthelsen AK, et al
    The optimal use of imaging in Radiation Therapy for lymphoma - Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2019 Feb 11. pii: S0360-3016(19)30191.
    PubMed     Text format     Abstract available


  3. PAUDEL N, Schulze D, Gentzler RD, Evens AM, et al
    Patterns of Failure and Survival Outcomes After Total Lymphoid Irradiation and High-Dose Chemotherapy With Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Feb 11. pii: S0360-3016(19)30197.
    PubMed     Text format     Abstract available


    December 2018
  4. WIRTH A, Prince HM, Roos D, Gibson J, et al
    A prospective, multicentre study of involved-field radiotherapy with autologous stem cell transplantation for patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma (ALLG HDNHL04/TROG 03.03).
    Int J Radiat Oncol Biol Phys. 2018 Dec 13. pii: S0360-3016(18)34123.
    PubMed     Text format     Abstract available


    November 2018
  5. DEMISSEI BG, Freedman G, Feigenberg SJ, Plastaras JP, et al
    Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer and lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33999.
    PubMed     Text format     Abstract available


  6. DABAJA BS, Specht L, Yahalom J
    Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2018;102:508-514.
    PubMed     Text format     Abstract available


    October 2018
  7. BAKST RL, Dabaja BS, Specht LK, Yahalom J, et al
    Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;102:314-319.
    PubMed     Text format     Abstract available


    September 2018
  8. QI F, Wang WH, He XH, Chen B, et al
    Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.
    Int J Radiat Oncol Biol Phys. 2018;102:61-70.
    PubMed     Text format     Abstract available


  9. BOVI JA, Schultz CJ, Mehta MP, Corn BW, et al
    Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order.
    Int J Radiat Oncol Biol Phys. 2018;102:59-60.
    PubMed     Text format    


  10. PINNIX CC, Yahalom J, Specht L, Dabaja BS, et al
    Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;102:53-58.
    PubMed     Text format    


    July 2018
  11. TSANG RW, Campbell BA, Goda JS, Kelsey CR, et al
    Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;101:794-808.
    PubMed     Text format     Abstract available


  12. WONG JYC, Filippi AR, Dabaja BS, Yahalom J, et al
    Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
    Int J Radiat Oncol Biol Phys. 2018;101:521-529.
    PubMed     Text format     Abstract available


    April 2018
  13. PARZUCHOWSKI A, Bush R, Pei Q, Friedman DL, et al
    Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.
    Int J Radiat Oncol Biol Phys. 2018;100:1119-1125.
    PubMed     Text format     Abstract available


  14. CONSTINE LS, Yahalom J, Ng AK, Hodgson DC, et al
    The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;100:1100-1118.
    PubMed     Text format     Abstract available


    March 2018
  15. PINNIX CC, Cella L, Andraos TY, Ayoub Z, et al
    Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Mar 14. pii: S0360-3016(18)30495.
    PubMed     Text format     Abstract available


  16. NG AK, Yahalom J, Goda JS, Constine LS, et al
    Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;100:652-669.
    PubMed     Text format     Abstract available


  17. RANA S, Holland J
    Coping With Knife: Postoperative Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2018;100:547-548.
    PubMed     Text format    


  18. MARQUEZ C
    Observe, and Keep Chemotherapy Up the Sleeve.
    Int J Radiat Oncol Biol Phys. 2018;100:550.
    PubMed     Text format    


  19. SANGHVI P
    Involved-Site Radiation to Maximize Control.
    Int J Radiat Oncol Biol Phys. 2018;100:549.
    PubMed     Text format    


  20. KALLAM A, Armitage JO
    Watch and Wait, Salvage Later.
    Int J Radiat Oncol Biol Phys. 2018;100:549-550.
    PubMed     Text format    


    January 2018
  21. MILGROM SA, Pinnix CC, Chi TL, Vu TH, et al
    Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Jan 6. pii: S0360-3016(18)30003.
    PubMed     Text format     Abstract available


    October 2017
  22. THOMAS J, Ferme C, Noordijk EM, Morschhauser F, et al
    Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2017 Oct 27. pii: S0360-3016(17)33984.
    PubMed     Text format     Abstract available


  23. PATEL CG, Michaelson E, Chen YH, Silver B, et al
    Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2017 Oct 5. pii: S0360-3016(17)33954.
    PubMed     Text format     Abstract available


  24. NANDA R, Flampouri S, Mendenhall NP, Indelicato DJ, et al
    Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;99:494-497.
    PubMed     Text format    


    September 2017
  25. ARISTOPHANOUS M, Chi PM, Kao J, Williamson R, et al
    Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins.
    Int J Radiat Oncol Biol Phys. 2017 Sep 25. pii: S0360-3016(17)33936.
    PubMed     Text format     Abstract available


  26. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
    Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
    PubMed     Text format    


  27. WILKE C, Cao Q, Dusenbery KE, Bachanova V, et al
    Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;99:94-102.
    PubMed     Text format     Abstract available


  28. CHANG JY, Zhang X, Knopf A, Li H, et al
    Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017;99:41-50.
    PubMed     Text format     Abstract available


    August 2017
  29. MELCHERS RC, Willemze R, Daniels LA, Neelis KJ, et al
    Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33721.
    PubMed     Text format     Abstract available


  30. HAHN E, Jiang H, Ng A, Bashir S, et al
    Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
    Int J Radiat Oncol Biol Phys. 2017;98:1116-1123.
    PubMed     Text format     Abstract available


    July 2017
  31. KRUL IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, et al
    Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Int J Radiat Oncol Biol Phys. 2017 Jul 18. pii: S0360-3016(17)33598.
    PubMed     Text format     Abstract available


    June 2017
  32. MORRIS S, Scarisbrick J, Frew J, Irwin C, et al
    The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Jun 9. pii: S0360-3016(17)31003.
    PubMed     Text format     Abstract available


    April 2017
  33. VARGO JA, Ward MC, Caudell JJ, Riaz N, et al
    A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Apr 24. pii: S0360-3016(17)30821.
    PubMed     Text format     Abstract available


  34. RIMNER A, Lovie S, Hsu M, Chelius M, et al
    Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.
    Int J Radiat Oncol Biol Phys. 2017;97:1066-1076.
    PubMed     Text format     Abstract available


    February 2017
  35. EL-FAYECH C, Haddy N, Allodji RS, Veres C, et al
    Cerebrovascular Diseases in Childhood Cancer Survivors: Role of the Radiation Dose to Willis Circle Arteries.
    Int J Radiat Oncol Biol Phys. 2017;97:278-286.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: